Research is intrinsic to the advancement of healthcare. Without it, there are no new treatments or cures to safely bring to patients. Learn more about the research we do, and how we are improving the health and well-being of children around the world.
As part of The Center for Cellular and Molecular Therapeutics, the Research Vector Core (RVC) has expanded its capacity to provide infrastructure support for investigators interested in using viral vectors in their research model systems.
The Mitochondrial Research Affinity Group has been created to address the needs of the diverse community of researcher engaged in mitochondria-focused research. Due to the importance of mitochondrial biology in many forms of disease, the clinical backgrounds of these investigators are wide-ranging and include clinical genetics, metabolism, endocrinology, anesthesiology, hematology, oncology, gastroenterology, neonatology, immunology, neurology, pathology, and ophthalmology.
The BSL3 facility, located in Abramson 1203C, allows investigators working with potentially pathogenic agents, such as HIV, hepatitis and herpes simplex, among others, access to flow cytometry and cell sorting for live, unfixed material. By having access to the state-of-the-art cell sorter, users of the facility can perform the most sophisticated flow cytometric analyses.